Amy Cohen is running the New York City Marathon despite living with the painful effects of sickle cell disease.

Twenty-month-old Vida Rodriguez is the reason her 7-year-old sister, Alessia, is playing at home — instead of lying in a ...

The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...

Life expectancy has soared and interest in the disease is growing, but breakthrough gene therapies are extraordinarily ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Sickle cell disease, a genetic blood disorder, disproportionately affects Black individuals, with one in 365 Black babies born with it in the U.S. New, high-cost gene therapies offer potential cures ...

A contingent of Jamaican business and cultural figures visiting London’s newest blood donor centre to raise awareness about ...

In the small, single-room house of the Vadakottathara Iruala settlement in Attappadi, seven-year-old Amritalakshmi’s smiling photograph now rests where she once slept beside her siblings.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease ...

Beam Therapeutics, Inc. (($BEAM)) announced an update on their ongoing clinical study. Beam Therapeutics, Inc. is conducting the BEACON trial, ...